Brief: Aptar’S N-Sorb Nitrosamine Mitigation Solution Accepted To Us FDA’S Emerging Technology Program
Aptargroup Inc ATR.N :
* APTAR’S N-SORB NITROSAMINE MITIGATION SOLUTION ACCEPTED TO
US
FDA’S EMERGING TECHNOLOGY PROGRAM
Source text for Eikon: ID:nBw42xlrWa
Further company coverage: ATR.N
Recent news on AptarGroup
See all newsBrief: Aptargroup Note Decree Of President Of Russian Federation
Russia puts Aptar Europe Holding under temporary administration
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Aptargroup Inc reports results for the quarter ended June 30 - Earnings Summary
Aptar Q2 sales beat estimates on strength in consumer healthcare and injectables